Table 2.
Genes identified by at least two microarray studies of ARF
| Gene name | Studies that identify gene changes after ARF | |||||||
|---|---|---|---|---|---|---|---|---|
| Cyclin-dependent kinase inhibitor 1A (Cdkn1a)/p21/WAF | A | C | D | E | G | H | ||
| Epidermal growth factor (EGF) | A | C | E | F | G | H | ||
| Clusterin (Clu) | A | B | E | F | H | |||
| A kinase (PRKA) anchor protein (gravin) 12 (Akap12) | C | D | E | H | ||||
| Heme oxygenase (decycling) 1 (Hmox1) | B | D | F | H | ||||
| Kidney injury molecule 1 (Havcr1)/KIM-1 | C | E | F | H | ||||
| Lipocalin 2 (Lcn2)/NGAL | D | E | F | H | ||||
| Afamin (Afm)/alpha-albumin | B | D | H | |||||
| Annexin A2 (Anxa2)/Calpactin I | C | E | H | |||||
| c-Fos | D | G | H | |||||
| Claudin 7 (Cldn7) | D | E | H | |||||
| Early growth response 1 (Egr1) | D | E | H | |||||
| H1 histone family, member 0 (Icam1) | E | G | H | |||||
| Heat shock 70kD protein 1A (Hspa1a)/hsp70 | D | E | H | |||||
| Interleukin 6 (Il6) | D | E | H | |||||
| Lectin, galactose binding, soluble 3 (Lgals3)/Mac-2 antigen | C | E | H | |||||
| Leukemia inhibitory factor receptor (Lifr) | C | E | H | |||||
| Metallothionein (Mt1a) | D | E | H | |||||
| Solute carrier family 9, member 3 (Slc9a3)/NHE3 | D | G | H | |||||
| Solute carrier family 16 (monocarboxylic acid transporters), member 7 (Slc16a7) | C | E | H | |||||
| CD68 antigen (Cd68) | C | D | E | |||||
| Tubulin, beta 5 (Tubb5) | C | D | E | |||||
| Activating transcription factor 3 (Atf3) | E | H | ||||||
| Adrenomedullin (Adm) | E | H | ||||||
| Alpha-2-macroglobulin (A2m) | D | H | ||||||
| Annexin A1 (Anxa1)/Lipocortin 1 | E | H | ||||||
| Aspartoacylase (Aspa) | E | H | ||||||
| CD44 antigen (Cd44) | A | H | ||||||
| Chemokine (C-X-C motif) ligand 12 (Cxcl12)/SDF-1 | E | H | ||||||
| DnaJ (Hsp40) homolog, subfamily B, member 9 (Dnajb9) | D | H | ||||||
| Eukaryotic translation initiation factor 1A (Eif1a) | E | H | ||||||
| Fibrinogen, B beta polypeptide (Fgb) | C | H | ||||||
| FK506-binding protein 1a (Fkbp1a) | B | H | ||||||
| Fos-like antigen 1 (Fosl1) | E | H | ||||||
| Growth differentiation factor 15 (Gdf15) | C | H | ||||||
| Insulin-like growth factor binding protein 5 (Igfbp5) | D | H | ||||||
| Lactate dehydrogenase A (Ldha) | D | H | ||||||
| Myelocytomatosis viral oncogene homolog (avian) (Myc)/c-Myc | A | H | ||||||
| Procollagen, type I, alpha 1 (Col1a1) | C | H | ||||||
| Ras-related associated with diabetes (Rrad) | D | H | ||||||
| Solute carrier family 30 (zinc transporter), member 1 (Slc30a1)/ZnT1 | D | H | ||||||
| Solute carrier organic anion transporter family, member 1a1 (Slco1a1)/Organic anion transporting polypeptide 1 (OATP-1) | A | H | ||||||
| Sphingosine kinase 1 (Sphk1) | D | H | ||||||
| Transgelin (Tagln) | E | H | ||||||
| Tropomyosin 4 (Tpm4) | D | H | ||||||
| Tumor necrosis factor receptor superfamily, member 12a (Tnfrsf12a) | F | H | ||||||
| V-jun sarcoma virus 17 oncogene homolog (avian) (Jun) | G | H | ||||||
| Actin, alpha 2, smooth muscle, aorta (Acta2) | C | E | ||||||
| Annexin A3 (Anxa3) | C | E | ||||||
| Aquaporin 1 (Aqp1) | D | E | ||||||
| CD14 antigen (Cd14) | D | E | ||||||
| Chemokine (C-X-C motif) ligand 1 (Cxcl1)/GRO-1 | C | E | ||||||
| Cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14) | B | D | ||||||
| Growth arrest specific 2 (Gas2) | C | E | ||||||
| Insulin-like growth factor binding protein 1 (Igfbp1) | A | C | ||||||
| myosin Va | C | D | ||||||
| procollagen III | C | D | ||||||
| Procollagen, type XVIII, alpha 1 | C | E | ||||||
| Proline dehydrogenase (oxidase) 2 (Prodh2)/kidney and liver proline oxidase 1 | D | E | ||||||
| Stratifin (Sfn)/14-3-3 protein sigma | D | E | ||||||
| Uromodulin (Umod)/(uromucoid, Tamm-Horsfall glycoprotein) | B | G | ||||||
| Vascular cell adhesion molecule 1 (Vcam1) | C | E | ||||||